2017年ACC/AHA定义下血压升高与1级高血压的围产期结局
该回顾性队列研究纳入2013至2019年18801例单胎妊娠女性,依据2017年ACC/AHA标准分为正常血压、血压升高、1级高血压和慢性高血压组。结果显示血压升高和1级高血压与妊娠期高血压疾病风险增加相关,且1级高血压还增加新生儿ICU入住、早产和妊娠期糖尿病风险。
要点
- 血压升高和1级高血压与妊娠期高血压疾病风险呈剂量反应关系。
- 1级高血压增加新生儿ICU入住、<37周早产和妊娠期糖尿病风险。
- 需进一步研究是否可通过孕期管理降低该人群母儿发病率。
核心结论
- 按2017年ACC/AHA标准定义的血压升高和1级高血压与母儿风险增加相关。
研究设计与样本
- 回顾性队列研究,纳入2013至2019年18801例单胎妊娠女性。
- 依据孕20周前血压将孕妇分为正常血压、血压升高、1级高血压和慢性高血压组。
主要发现
- 妊娠期高血压疾病发生率从正常血压组的4.2%升至血压升高组的6.7%(aOR 1.50,95%CI 1.26-1.79)。
- 1级高血压组妊娠期高血压疾病发生率为10.9%(aOR 2.54,95%CI 2.09-3.08),慢性高血压组为28.4%(aOR 7.14,95%CI 6.06-8.40)。
- 与正常血压组相比,1级高血压组新生儿ICU入住率15.8% vs 13.0%(aOR 1.21,95%CI 1.03-1.42)。
- 1级高血压组<37周早产率7.2% vs 5.2%(aOR 1.45,95%CI 1.16-1.81),妊娠期糖尿病率14.8% vs 6.8%(aOR 2.68,95%CI 2.27-3.17)。
临床怎么用
- 临床应关注孕20周前血压处于血压升高或1级高血压范围的孕妇,加强妊娠期高血压疾病监测。
- 对1级高血压孕妇需警惕新生儿ICU入住、早产和妊娠期糖尿病风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hypertension was redefined in 2017 with lower diagnostic thresholds; elevated blood pressure is defined as systolic blood pressure of 120 to 129 mm Hg with diastolic blood pressure of <80 mm Hg and stage 1 hypertension as systolic blood pressure of 130 to 139 mm Hg or diastolic blood pressure of 80 to 89 mm Hg. These guidelines did not include pregnant women. There is limited information on stage 1 hypertension and pregnancy outcomes. OBJECTIVE: This study aimed to determine whether elevated blood pressure and stage 1 hypertension as newly defined by the 2017 American College of Cardiology and the American Heart Association guidelines are associated with an increased risk of hypertensive disorders of pregnancy and other adverse maternal and neonatal outcomes. STUDY DESIGN: In this retrospective cohort study, 18,801 women with singletons from 2013 to 2019 were categorized as normotensive, prehypertensive (elevated blood pressure), stage 1 hypertensive, or chronic hypertensive. Women with ≥2 systolic blood pressures of 120 to 129 mm Hg before 20 weeks' gestation were classified into the elevated blood pressure group. Women with ≥2 systolic blood pressures of 130 to 139 mm Hg or ≥2 diastolic blood pressures of 80 to 89 mm Hg before 20 weeks' gestation were assigned to the stage 1 hypertension group. Women were classified as chronic hypertensives if they had any of the following: ≥2 systolic blood pressure of ≥140 mm Hg or ≥2 diastolic blood pressure of ≥90 mm Hg before 20 weeks' gestation, a history of chronic hypertension, or antihypertensive medication use before 20 weeks' gestation. Women with pregestational diabetes, lupus, or <2 blood pressures before 20 weeks' gestation were excluded. The association of stage 1 hypertension with the risk of developing hypertensive disorders of pregnancy was estimated using multivariate logistic regression controlling for maternal sociodemographic characteristics, gestational weight gain by prepregnancy body mass index, parity, and aspirin use. Secondary outcomes included subgroups of hypertensive disorders (gestational hypertension, preeclampsia, eclampsia, and hemolysis, elevated liver enzymes, and low platelet count syndrome), gestational diabetes, placental abruption, intrauterine growth restriction, preterm birth, neonatal intensive care unit admission, stillbirth and neonatal death, and maternal intensive care unit admission. All outcomes were adjusted for potential confounders. RESULTS: Of the 18,801 women, 13,478 (71.7%) were normotensive, 2659 (14.1%) had elevated blood pressure, 1384 (7.4%) were stage 1 hypertensive, and 1280 (6.8%) were chronic hypertensive. A dose-response relationship was observed: the risk of hypertensive disorders of pregnancy increased from 4.2% in normotensive women to 6.7% (adjusted odds ratio, 1.50; 95% confidence interval, 1.26-1.79) in women with elevated blood pressure, to 10.9% (adjusted odds ratio, 2.54; 95% confidence interval, 2.09-3.08) in women with stage 1 hypertension, and 28.4% (adjusted odds ratio, 7.14; 95% confidence interval, 6.06-8.40) in women with chronic hypertension. Compared with normotensive women, women with stage 1 hypertension had an increased risk of neonatal intensive care unit admissions (15.8% vs 13.0%; adjusted odds ratio, 1.21; 95% confidence interval, 1.03-1.42), preterm birth at <37 weeks' gestation (7.2% vs 5.2%; adjusted odds ratio, 1.45; 95% confidence interval, 1.16-1.81), and gestational diabetes (14.8% vs 6.8%; adjusted odds ratio, 2.68; 95% confidence interval, 2.27-3.17). CONCLUSION: Our study demonstrates that elevated blood pressure and stage 1 hypertension, using the 2017 American College of Cardiology and the American Heart Association guideline definition, are associated with increased maternal and neonatal risk. This group of women warrants further investigation to determine whether pregnancy management can be altered to reduce maternal and neonatal morbidity.
引用
- Greenberg VR, Silasi M, Lundsberg LS, et al. Perinatal outcomes in women with elevated blood pressure and stage 1 hypertension. Am J Obstet Gynecol. 2020. PMID: 33157064. doi:10.1016/j.ajog.2020.10.049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。